Bumetanide Nasal Spray (RSQ-777) is being developed as a convenient, outpatient-focused therapy for edema associated with congestive heart failure, as well as liver and kidney disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback